We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DBK:XETRDeutsche Bank Aktiengesellschaft Analysis

Data as of 2026-03-10 - not real-time

€26.55

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Deutsche Bank is trading well below its 20‑day and 50‑day moving averages, with the price hovering near a strong support at roughly €25.9. Valuation metrics such as a trailing P/E near 8x versus an industry average of over 17x and a price‑to‑book under 0.7 suggest the stock is materially undervalued, offering an estimated upside of more than 25% to analyst targets. Technical signals are mixed: the RSI sits in the oversold region (~29), hinting at potential short‑term bounce, while the MACD remains bearish, tempering expectations of a rapid rally. The recent announcement of a dividend increase to €1.00 further bolsters the income appeal, with a payout ratio around 21% indicating sustainability.
Given the increasing volume trend and a moderate beta below 1, downside volatility appears contained, but the bank’s exposure to European economic cycles and regulatory scrutiny adds a layer of medium‑term uncertainty. Investors should weigh the attractive valuation and dividend yield against the neutral technical outlook and sector‑specific risks when positioning for the next few months.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near strong support level
  • Oversold RSI indicating possible bounce
  • Bearish MACD histogram limiting upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount to peers
  • Increasing dividend and sustainable payout
  • Analyst price targets implying >25% upside

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Stable earnings growth and improving revenue trajectory
  • Robust balance sheet with ample cash relative to debt
  • Continued dividend growth supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth7.70%
Profit Margin22.81%
P/E Ratio8.3
ROE8.94%
ROA0.51%
P/B Ratio0.6
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI29.2
Support€25.86
Resistance€32.09
MA 20€29.79
MA 50€31.70
MA 200€29.66
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89

Valuation

Target Price€33.65
Upside/Downside26.74%
GradeUndervalued
TypeValue
Dividend Yield3.71%

Risk Assessment

Beta0.72
Volatility37.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.